Skeberdis V A, Jurevicius J, Fischmeister a R
Laboratoire de Cardiologie Cellulaire et Moléculaire, INSERM U-446, Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France.
J Pharmacol Exp Ther. 1997 Nov;283(2):452-61.
The whole-cell patch-clamp and intracellular perfusion techniques were used for studying the effects of a beta-2 adrenergic receptor activation on the L-type Ca current (ICa) in frog ventricular myocytes. The beta-2 adrenergic agonist zinterol increased ICa in a concentration-dependent manner with an EC50 (i.e., the concentration of zinterol at which the response was 50% of the maximum) of 2.2 nM. The effect of zinterol was essentially independent of the membrane potential. The stimulatory effect of zinterol was competitively antagonized by ICI 118,551, a beta-2 adrenergic antagonist. The maximal stimulatory effect of zinterol was comparable in amplitude to the effect of a saturating concentration (1 or 10 microM) of isoprenaline, a nonselective beta adrenergic agonist. Moreover, 3-isobutyl-1-methylxanthine (100 microM), a nonselective phosphodiesterase inhibitor, or forskolin (10 microM), a direct activator of adenylyl cyclase, had no additive effects in the presence of 0.1 microM zinterol. Zinterol had a long lasting action on frog ICa because after washout of the drug, ICa returned to basal level with a time constant of 17 min. An application of acetylcholine (1 microM) during this recovery phase promptly reduced ICa back to its basal level suggesting a persistent activation of adenylyl cyclase due to a slow dissociation rate constant of zinterol from its receptor. Zinterol also increased ICa in rat ventricular and human atrial myocytes, and the maximal effect was obtained at 10 and 1 microM, respectively. In all three preparations, intracellular perfusion with 20 microM PKI(15-22), a highly selective peptide inhibitor of cAMP-dependent protein kinase, completely antagonized the stimulatory effect of zinterol on ICa. We conclude that beta-2 adrenergic receptor activation produces a strong increase in ICa in frog, rat and human cardiac myocytes which is due to stimulation of adenylyl cyclase and activation of cAMP-dependent phosphorylation.
采用全细胞膜片钳和细胞内灌流技术,研究β2肾上腺素能受体激活对蛙心室肌细胞L型钙电流(ICa)的影响。β2肾上腺素能激动剂齐帕特罗以浓度依赖的方式增加ICa,其半数有效浓度(EC50,即反应达到最大反应50%时齐帕特罗的浓度)为2.2 nM。齐帕特罗的作用基本与膜电位无关。齐帕特罗的刺激作用被β2肾上腺素能拮抗剂ICI 118,551竞争性拮抗。齐帕特罗的最大刺激作用在幅度上与饱和浓度(1或10 μM)的非选择性β肾上腺素能激动剂异丙肾上腺素的作用相当。此外,在存在0.1 μM齐帕特罗的情况下,非选择性磷酸二酯酶抑制剂3-异丁基-1-甲基黄嘌呤(100 μM)或腺苷酸环化酶直接激活剂福斯可林(10 μM)没有相加作用。齐帕特罗对蛙ICa有持久作用,因为在药物洗脱后,ICa以17分钟的时间常数恢复到基础水平。在这个恢复阶段应用乙酰胆碱(1 μM)可迅速将ICa降低回基础水平,这表明由于齐帕特罗从其受体解离的速率常数较慢,腺苷酸环化酶持续激活。齐帕特罗也增加大鼠心室肌细胞和人心房肌细胞的ICa,最大效应分别在10 μM和1 μM时获得。在所有三种制剂中,用20 μM PKI(15 - 22)(一种cAMP依赖性蛋白激酶的高度选择性肽抑制剂)进行细胞内灌流,完全拮抗了齐帕特罗对ICa的刺激作用。我们得出结论,β2肾上腺素能受体激活导致蛙、大鼠和人心肌细胞的ICa显著增加,这是由于腺苷酸环化酶的刺激和cAMP依赖性磷酸化的激活。